You have 9 free searches left this month | for more free features.

pharmacological imaging

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDD Trial in Vienna (Ketamine, Placebo)

Recruiting
  • Major Depressive Disorder
  • Vienna, Austria
    Medical University of Vienna
Jul 14, 2022

Coronary Artery Disease Trial in Aarhus N ([O-15]-Water PET Myocardial Perfusion Imaging (MPI))

Recruiting
  • Coronary Artery Disease
  • [O-15]-Water PET Myocardial Perfusion Imaging (MPI)
  • Aarhus N, Denmark
    Aarhus University Hospital
Jun 10, 2022

Adenocarcinoma of the Prostate, Stage IIB Prostate Cancer, Stage III Prostate Cancer Trial in Duarte (biological, procedure,

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +3 more
  • anti-PSMA monoclonal antibody MDX1201-A488
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Recurrent Plasma Cell Myeloma, Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte (biological, drug, procedure, other)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • +2 more
  • Daratumumab
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Neuro-Degenerative Disease, Cancer Trial in New York (Clonidine Pill)

Terminated
  • Neuro-Degenerative Disease
  • Cancer
  • Clonidine Pill
  • New York, New York
    Weill Cornell Medicine
Jun 21, 2021

Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer Trial in Duarte (procedure, other, drug)

Active, not recruiting
  • Breast Cancer
  • +11 more
  • radionuclide imaging
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Oct 20, 2022

Colorectal Cancer, Metastatic Colorectal Cancer, RAS Wild Type Colorectal Cancer Trial in Nashville (drug, biological, other,

Recruiting
  • Colorectal Cancer
  • +3 more
  • Glutaminase Inhibitor CB-839
  • +5 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Mar 29, 2022

Cardiovascular Disease, Atherosclerosis, Coronary Artery Disease Trial in Houston (Comprehensive therapy program for risk factor

Active, not recruiting
  • Cardiovascular Disease
  • +3 more
  • Comprehensive therapy program for risk factor modification
  • Houston, Texas
    Weatherhead PET Center, Memorial Hermann Hospital TMC
May 20, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (drug, radiation,

Completed
  • Adenocarcinoma of the Prostate
  • +3 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Aug 3, 2021

Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma, Advanced Cervical Squamous Cell Carcinoma Trial in

Recruiting
  • Advanced Cervical Adenocarcinoma
  • +12 more
  • Biospecimen Collection
  • +11 more
  • Los Angeles, California
  • +15 more
Aug 23, 2022

MDD Trial (Ketamine Hydrochloride, Esketamine, Placebo)

Not yet recruiting
  • Major Depressive Disorder
  • Ketamine Hydrochloride
  • +2 more
  • (no location specified)
Oct 8, 2020

Cognitive Impairment Trial in New Haven (MRI, Ketamine)

Completed
  • Cognitive Impairment
  • New Haven, Connecticut
    Magnetic Resonance Research Center
Jun 29, 2020

Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

Recruiting
  • Myelodysplastic Syndrome
  • +16 more
  • Computed Tomography
  • +6 more
  • Scottsdale, Arizona
  • +2 more
Feb 3, 2022

Lumbar Disc Herniation Trial in Korea, Republic of (non-pharmacological treatment strategy, pharmacological treatment strategy)

Recruiting
  • Lumbar Disc Herniation
  • non-pharmacological treatment strategy
  • pharmacological treatment strategy
  • Seoul, Gangnam-Gu, Korea, Republic of
  • +3 more
Aug 29, 2023

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

ADHD, Executive Dysfunction Trial (Goal Management training)

Not yet recruiting
  • Attention Deficit Hyperactivity Disorder
  • Executive Dysfunction
  • Goal Management training
  • (no location specified)
May 26, 2023

Vestibular Migraine Trial in Kuala Lumpur (Lifestyle modifications, Vestibular rehabilitation exercise)

Not yet recruiting
  • Vestibular Migraine
  • Lifestyle modifications
  • Vestibular rehabilitation exercise
  • Kuala Lumpur, Malaysia
    Universiti Malaya Medical Centre
Jun 19, 2023

Schizophrenia Trial in Bangalore (oxytocin)

Completed
  • Schizophrenia
  • Bangalore, Karnataka, India
    National Institute of Mental Health and Neurosciences
Nov 6, 2019

Coronary Artery Disease (CAD) Trial in Worldwide (PET MPI, SPECT MPI, Pharmacological stress agents)

Completed
  • Coronary Artery Disease (CAD)
  • PET MPI
  • +2 more
  • Birmingham, Alabama
  • +52 more
May 18, 2022

Diabetic Peripheral Neuropathy Trial (Non-pharmacological Heat, Pressure, and Vibration)

Not yet recruiting
  • Diabetic Peripheral Neuropathy
  • Non-pharmacological Heat, Pressure, and Vibration
  • (no location specified)
Jan 31, 2023

Fibromyalgia, Hyperbaric Oxygen Trial in Zerifin (Hyperbaric oxygen therapy, Cymbalta / lyrica, Crossover Hyperbaric oxygen

Completed
  • Fibromyalgia
  • Hyperbaric Oxygen
  • Hyperbaric oxygen therapy
  • +2 more
  • Zerifin, Israel
    Assaf-Harofeh Medical Center
Jul 6, 2022

Seeks to Understand Clinical, Genomic, Pharmacological,

Not yet recruiting
  • Purine-Pyrimidine Metabolism
  • Metabolic Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 26, 2023

    Schizophrenia; Psychosis Trial in Nashville (Levetiracetam (LEV) 500 mg, Placebo)

    Recruiting
    • Schizophrenia; Psychosis
    • Levetiracetam (LEV) 500 mg
    • Placebo
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Mar 15, 2022

    Bipolar Disorder Trial in Leiden (lithium MRSI)

    Not yet recruiting
    • Bipolar Disorder
    • lithium MRSI
    • Leiden, Zuid Holland, Netherlands
      Leiden University Medical Center
    Nov 15, 2023